Reduced-intensity conditioning for allogeneic stem cell transplantation in patients with chronic myeloid leukemia is associated with better overall survival but inferior disease-free survival when compared with myeloablative conditioning - A retrospective study of the Czech National Hematopoietic Stem Cell Transplantation Registry

Neoplasma

Volumn 54, Issue 5, 2007, Pages 443-446

  Faber, E ^a   Koza, V ^b   Vitek, A ^c   Mayer, J ^d   Sedlacek, P ^e   Zak, P ^f   Zapletalova, J ^a   Benesova, K ^g   Krejcova, H ^g   Steinerova, K ^b   Maresova, I ^a   Cetkovsky, P ^c  

^a UNIVERSITY HOSPITAL OLOMOUC   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION   (Czech Republic)

^d UNIVERSITY HOSPITAL BRNO   (Czech Republic)

^e UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

^f UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

^g Czech National Registry of Hematopoietic Stem Cell Transplantation   (Czech Republic)

Author keywords

Allogeneic stem cell transplantation; Chronic myeloid leukemia; Imatinib; Reduced intensity conditioning

Indexed keywords

ACUTE GRAFT VERSUS HOST DISEASE; ADOLESCENT; ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; CANCER SURVIVAL; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; CZECH REPUBLIC; DISEASE FREE SURVIVAL; FEMALE; HUMAN; INTERMETHOD COMPARISON; LOG RANK TEST; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYELOABLATIVE CONDITIONING; OVERALL SURVIVAL; RECURRENCE RISK; REDUCED INTENSITY CONDITIONING; RISK ASSESSMENT; WHOLE BODY RADIATION; CHRONIC DISEASE; CLINICAL TRIAL; DONOR; IMMUNOSUPPRESSIVE TREATMENT; METHODOLOGY; MULTICENTER STUDY; MYELOID LEUKEMIA; REGISTER; RETROSPECTIVE STUDY; STATISTICS; STEM CELL TRANSPLANTATION; SURVIVAL;

CHRONIC DISEASE; CZECH REPUBLIC; DISEASE-FREE SURVIVAL; HUMANS; LEUKEMIA, MYELOID; LEUKEMIA, MYELOID, CHRONIC; REGISTRIES; RETROSPECTIVE STUDIES; STEM CELL TRANSPLANTATION; SURVIVAL ANALYSIS; TISSUE DONORS; TRANSPLANTATION CONDITIONING;

EID: 35448946467     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. GRATWOHL A, BALDOMERO H, HORISBERGER B, et al. Current trends in hematopoietic stem cell transplantation in Europe. Blood 2002; 100: 2374-2386.
2. BACCARANI M, SAGLIO G, GOLDMAN JM, et al. Evolving concepts in the management of chronic myeloid leukemia. Recommendations from an expert panel on behalf of the European LeukemiaNet. Blood 2006; 108: 1809-1820.
3. ROBIN M, GUARDIOLA P, DEVERGIE A, et al. A 10-year median follow-up study after allogeneic stem cell transplantation for chronic myeloid leukemia in chronic phase from HLA-identical sibling donors. Leukemia 2005; 19: 1613-1620.
4. OR R, SHAPIRA MY, RESNICK I, et al. Nonmyeloablative allogeneic stem cell transplantation for the treatment of chronic myeloid leukemia in first chronic phase. Blood 2003; 101: 441-445. (Pubitemid 36077561)
5. CRAWLEY C, SZYDLO R, LALANCETTE M, et al. Outcomes of reduced-intensity transplantation for chronic myeloid leukemia: an analysis of prognostic factors from the Chronic Leukemia Working Party of the EBMT. Blood 2005; 106: 2969-2976. (Pubitemid 41565887)
6. FABER E, VÍTEK A, KOZA V, et al. Allogeneic stem cell transplantation in patients with chronic myeloid leukemia in Czech Republic: results of a retrospective analysis from the Czech National Registry and Pilsen. Bone Marrow Transplant 2006; 37 (Suppl 1): S226 (Abstract P836).
7. RADICH JP, OLAVARRIA E, APPERLEY JF. Allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia. Hematol Oncol Clin N Am 2004; 18: 685-702. (Pubitemid 38969139)
8. SCHMITZ N, BEKSAC M, BACIGALUPO A, et al. Filgrastim-mobilized peripheral blood progenitor cells versus bone marrow transplantation for treating leukemia: 3-year results from the EBMT randomized trial. Haematologica 2005; 90: 643-648. (Pubitemid 40780883)
9. OLAVARRIA E, KANFER E, SZYDLO R, et al. Early detection of BCR-ABL transcripts by quantitative reverse transcriptase-polymerase chain reaction predicts outcome after allogeneic stem cell transplantation for chronic myeloid leukemia. Blood 2001; 97: 1560-1565. (Pubitemid 32217216)